Results 261 to 270 of about 32,609 (300)

Medicinal Cannabis

American Journal of Hospice and Palliative Medicine, 2017
Beatriz H Carlini, Sharon B Garrett
exaly   +5 more sources

Medicinal cannabis in oncology

European Journal of Cancer, 2007
In The Netherlands, since September 2003, a legal medicinal cannabis product, constituting the whole range of cannabinoids, is available for clinical research, drug development strategies, and on prescription for patients. To date, this policy, initiated by the Dutch Government, has not yet led to the desired outcome; the amount of initiated clinical ...
Engels, Frederike K, de Jong, Floris A, Mathijssen, Ron H J, Erkens, Joëlle A, Herings, Ron M, Verweij, Jaap   +5 more
openaire   +3 more sources

Medicinal applications of cannabis/cannabinoids

Current Opinion in Psychology, 2021
Regulatory approvals for Epidiolex (purified cannabidiol) in the treatment of childhood drug resistant epilepsy have set a precedent for the use of cannabinoids as a prescribed medicine. Two common reasons cited for the use and prescription of cannabis-based products are pain and insomnia.
Irene Braithwaite, Chiranth Bhagavan, Marjan Doppen, Stacey Kung, Karen Oldfield, Giles Newton-Howes   +5 more
openaire   +2 more sources

Cannabis as medicine

BMJ, 2017
Evidence supports reform to allow the legitimate study, regulation, and prescription of therapeutic ...
openaire   +2 more sources

Cannabis and Veterinary Medicine

Veterinary Clinics of North America: Small Animal Practice
Cannabis and Veterinary Medicine explores the growing role of cannabis in veterinary medicine, highlighting its therapeutic potential and challenges. It discusses the complexities of the endocannabinoid system and its regulation of physiologic processes.
Gary, Richter, Trina, Hazzah
openaire   +2 more sources

Cannabis and Natural Cannabis Medicines

2007
Cannabis plants produce many compounds of possible medical importance. This chapter briefly explains the life cycle, origin, early evolution, and domestication of Cannabis, plus provides a brief history of drug Cannabis breeding and looks into the future of Cannabis as a source of medicines.
Robert C. Clarke, David P. Watson
openaire   +1 more source

Pharmacists and the future of cannabis medicine

Journal of the American Pharmacists Association, 2020
To summarize the history and evolution of cannabis use and policies and to review current therapeutic uses, safety, and the central role pharmacists can play.Cannabis regulation and use have evolved over the centuries and are becoming more widely accepted, with over two-thirds of states in the United States having an approved cannabis program. However,
Natalie, Schmitz, Lucas, Richert
openaire   +2 more sources

Medicinal Cannabis in Orthopaedic Practice

Journal of the American Academy of Orthopaedic Surgeons, 2020
Cannabis has gained widespread public advocacy since its legalization in several states with recent evidence suggesting that its self-reported use has increased in patients undergoing a primary total joint arthroplasty. The endocannabinoid system has been proposed to play a role in decreasing the inflammatory cascade and enhancing pain management.
Lindsay T. Kleeman-Forsthuber, Douglas A. Dennis, Jason M. Jennings   +2 more
openaire   +2 more sources

Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS‐16)

Medical Journal of Australia, 2018
To explore patterns of cannabis use for medical purposes in Australia immediately prior to the 2016 legislation for frameworks for medical cannabis use. Design, setting: Anonymous online survey with convenience sample, April-October 2016. Participants were recruited through online media and at professional and consumer forums.Adults (at least 18 years ...
Nicholas, Lintzeris, Jessica, Driels, Natalie, Elias, Jonathon C, Arnold, Iain S, McGregor, David J, Allsop   +5 more
openaire   +2 more sources

Rescheduling Cannabis—Medicine or Politics?

JAMA Psychiatry
ImportanceIn 2023, the US Department of Health and Human Services (HHS) issued a letter to the administrator of the Drug Enforcement Administration (DEA) recommending rescheduling of cannabis (marijuana) from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Bertha K, Madras, Paul J, Larkin
openaire   +2 more sources